|
Volumn 47, Issue , 2000, Pages 249-272
|
Major changes in sickle cell disease.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFEROXAMINE;
ENZYME INHIBITOR;
HEMOGLOBIN F;
HYDROXYUREA;
IMIDAZOLE;
IMIDAZOLE DERIVATIVE;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
GENE THERAPY;
GENETICS;
HEMOGLOBIN SC DISEASE;
HUMAN;
LIFE EXPECTANCY;
METABOLISM;
MORTALITY;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
DEFEROXAMINE;
ENZYME INHIBITORS;
FETAL HEMOGLOBIN;
GENE THERAPY;
HEMOGLOBIN SC DISEASE;
HUMANS;
HYDROXYUREA;
IMIDAZOLES;
LIFE EXPECTANCY;
RISK FACTORS;
|
EID: 0034564504
PISSN: 00653101
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (15)
|
References (57)
|